CIK 0001429260
- Non-accelerated filer
- Smaller reporting company
Fortress Biotech, Inc.
Sign in to watch- Ticker
- FBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 205157386
- Phone
- +1 781-652-4500
- Business address
- 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
- Former names
- Fortress Biotech, Inc., CORONADO BIOSCIENCES INC
Securities
- FBIO Common Stock Nasdaq
- FBIOP 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Nasdaq
- 4 Open-market buy Director bought 50,000 shares
- 4 Grant or award Director acquired 100,000 shares (grant or award)
- 4 Grant or award Director acquired 100,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 100,000 shares (grant or award)
- 4 Open-market buy Chief Financial Officer bought 2,297 shares at $1.10 ($2,527)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award PRESIDENT, CEO & CHAIRMAN acquired 396,825 shares (grant or award)
- 4/A Grant or award SVP, BIOLOGICS OPERATIONS acquired 400,000 shares (grant or award)
- 4 Grant or award EXECUTIVE VICE CHAIRMAN acquired 1,399,105 shares (grant or award)
- 4 Grant or award Director acquired 200,000 shares (grant or award)
- 4 Grant or award PRESIDENT AND CEO acquired 1,400,619 shares (grant or award)
- 4 Grant or award Director acquired 100,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 100,000 shares (grant or award)
- 4 Grant or award Director acquired 100,000 shares (grant or award)
- 4 Open-market sale SVP, BIOLOGICS OPERATIONS sold 97,325 shares at $1.05 ($102,191)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 100,000 shares (grant or award)
- 4 Grant or award Director acquired 100,000 shares (grant or award)
Page 7 of 15 · 289 filings